CClinicalTrials.gg
CompletedNCT03632694Updated Aug 15, 2018

The Move for Your Health Pilot Study

An interventional study of Health Coaching and Tech Support and Tech Support Only in Cancer, sponsored by Cindy Blair, PhD, MPH. Completed. Open to participants aged 60 Years and older. Per ClinicalTrials.gov, last updated 2018-08-15.

Sponsored by Cindy Blair, PhD, MPH · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Registered 2 years 1 month after the study started (first participant enrolled Jul 2016, registered Aug 2018).
Phase
Not applicable
Study type
Interventional
Enrollment
54
Allocation
Randomized
Ages
60 Years and older
Sex
All
01

Study summary

The Move for Your Health Pilot Study is a 16-week study in older cancer survivors to replace and break-up sedentary activity with short bouts of light physical activity.

Read the detailed description

This pilot study will determine the feasibility and acceptability of a mobile health (mHealth) intervention to replace and break-up sedentary time with intermittent bouts of light physical activity. The intervention uses an electronic activity monitor ("Jawbone UP2"; worn on the wrist) that pairs with a mobile app, which together promote awareness and enable self-monitoring of both physical activity (steps per day) and inactivity (wristband gently vibrates after a specified time of inactivity). Pre-post intervention change in objective, subjective, and biologic data will be compared between groups.

02

Conditions studied

  • Cancer

Keywords

  • cancer survivor
  • cancer survivorship
  • light physical activity
  • sedentary behavior
  • mHealth
  • Jawbone
03

In context

Lead sponsor

This is the only study on the registry with Cindy Blair, PhD, MPH as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
60 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Age 60 years or older at the time of enrollment
  • Diagnosed with local or regionally staged cancer (any site) and completed primary treatment
  • Own a smartphone capable of running the "Jawbone UP2" app
  • Willingness to be randomized to any of the 3 study arms, attend 2 clinic visits, and wear activity monitors (activPAL and actiGraph) at weeks 1 and 16 for 7 days; "Jawbone UP2" wristband monitor during weeks 2-16 during waking hours.
  • Able to read, speak, and understand English.
  • Living independently and capable of walking 3 blocks (approximately 1300 steps or 0.25 mile) without an assistive device (e.g., cane, walker)
  • Residence within Bernalillo County or the four surrounding counties (to reduce travel burden)

Exclusion criteria

Exclusion Criteria:

  • Currently participating in a program to decrease sedentary time or increase physical activity
  • Paid employment or volunteer position for greater than 20 hours per week
  • Severe impairments or pre-existing medical limitations for engaging in daily light physical activity
  • Wrist size >20 cm
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Investigator)
Enrollment
54 participants (actual)

Study arms

  • Experimental
    Health Coaching and Tech Support

    Participants receive tech support for using the "Jawbone UP2" activity monitor and smartphone app, and education materials and health coaching to achieve their goals to reduce sedentary time and increase their daily steps.

    Behavioral: Health Coaching and Tech Support

  • Active comparator
    Tech Support Only

    Participants receive tech support for using the "Jawbone UP2" activity monitor and smartphone app and education materials on reducing sedentary behavior.

    Behavioral: Tech Support Only

  • No intervention
    Waitlist Control

    Participants are instructed to maintain their regular activities. Upon completion of the 16-week intervention, participants receive the "Jawbone UP2" activity monitor, education materials, and one session of tech support/health coaching.

Interventions

  • BehavioralHealth Coaching and Tech Support

    Participants will receive a "Jawbone UP2" activity monitor and education materials about the negative consequences of sedentary behavior and suggestions for breaking up sedentary time with light physical activity. Participants receive 5 telephone coaching calls to set up the "Jawbone UP2" monitor with their smartphone app and receive tech support help with changing the settings/goals on the app. Additionally, this arm receives health coaching to provide encouragement and further motivate and help study participants to modify their sedentary behavior.

  • BehavioralTech Support Only

    Participants will receive a "Jawbone UP2" activity monitor and education materials about the negative consequences of sedentary behavior and suggestions for breaking up sedentary time with light physical activity. Participants receive 5 telephone coaching calls to set up the "Jawbone UP2" monitor with their smartphone app and receive tech support help with changing the settings/goals on the app. However, there is no additional health coaching.

06

What researchers measure

Primary outcomes

  1. Change in total volume of sedentary time (hours/day)

    Change in the average number of hours/day of sedentary time measured over a 1-week period using activPAL, at both baseline and 16-weeks post-intervention

    Time frame: Baseline to 16-weeks

  2. Change in the number of breaks in sedentary time

    Change in the average number of breaks in sedentary time measured over a 1-week period using activPAL, at both baseline and 16-weeks post-intervention

    Time frame: Baseline to 16-weeks

Secondary outcomes

  1. Change in light physical activity

    Change in the average number of hours per day spent in light physical activity (or higher intensity) measured over a 1-week period using activPAL, at both baseline and 16-weeks post-intervention

    Time frame: Baseline to 16-weeks

  2. Change in steps per day

    Change in the average number of steps per day measured over a 1-week period using activPAL, at both baseline and 16-weeks post-intervention

    Time frame: Baseline to 16-weeks

  3. Change in physical performance

    Change in the average physical performance score as measured by the Short Physical Performance Battery (SPPB). This performance battery includes chair stands, balance tests, and the 8-foot usual gait speed. Each subscale score ranges from 0 (cannot do) to 4 (good performance). The subscales are summed for a total score, which ranges from 0 (lowest level of performance) to 12 (highest level of performance)

    Time frame: Baseline to 16-weeks

  4. Change in physical functioning (ranging from basic to strenuous activities)

    Change in self-reported physical functioning as measured by the 36-item Short Form Survey (SF-36) physical functioning subscale. Raw scores range from 0 (worst functioning) to 100 (best functioning)

    Time frame: Baseline to 16-weeks

  5. Change in health-related quality of life (self-reported mental, physical, and social health and well-being)

    Change in quality of life as measured by the SF-36; each of the 8 subscales and 2 component summary scores; scores based on proprietary algorithm from Optum; higher scores represent better quality of life)

    Time frame: Baseline to 16-weeks

  6. Change in cardiometabolic markers

    Change in fasting glucose, insulin and lipids, as well as high-sensitivity C-Reactive Protein (CRP)

    Time frame: Baseline to 16-weeks

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Blair CK, Harding E, Wiggins C, Kang H, Schwartz M, Tarnower A, Du R, Kinney AY. A Home-Based Mobile Health Intervention to Replace Sedentary Time With Light Physical Activity in Older Cancer Survivors: Randomized Controlled Pilot Trial. JMIR Cancer. 2021 Apr 13;7(2):e18819. doi: 10.2196/18819. PubMed 33847588 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 15, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03632694
Lead sponsor
Cindy Blair, PhD, MPH
Collaborators
University of New Mexico Cancer Center, American Cancer Society, Inc.
Responsible party
Cindy Blair, PhD, MPH (Principal Investigator, University of New Mexico) — Sponsor-investigator
First posted
Aug 15, 2018
Start date
Jul 6, 2016
Primary completion
Jul 20, 2017
Completion
Jul 20, 2017
Last update
Aug 15, 2018

Study contacts

Cindy K Blair, PhD, MPH
principal investigator · University of New Mexico

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion